Catabasis Pharmaceuticals Stock News

Catabasis Pharmaceuticals Presents Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy

Taking care of your eye health is an everyday task that involves making wise lifestyle choices and practicing other preventive habits.

The move comes as the UAE has boosted capacity by opening new field hospitals across the country

Akmal was found guilty of two charges under the PCB Anti-Corruption Code and on April 27, he was banned from cricket activities till February 19, 2023.

The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...

The current destinations for return flights include Frankfurt and London.

Turkey’s currency has briefly dropped to an all-time low against the dollar as the country struggles with the economic impact of the coronavirus pandemic

Take your eye off the ball, and you might have just missed a home run. Veteran players of the stock picking game know that biotechs are capable of delivering a win at what feels like the drop of a hat

The

Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust (“REIT”) focused prima

The kidnappers use to present themselves as the NAB and law enforcement agency officials while approaching their target, initial probe reveals.

After Canaccord Genuity and Credit Suisse gave BioMarin Pharmaceutical (NASDAQ: BMRN) a Buy rating last month, the company received another Buy, this time

After Canaccord Genuity and Credit Suisse gave BioMarin Pharmaceutical (NASDAQ: BMRN) a Buy rating last month, the company received another

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on United Therapeutics (UTHR), with a price target of $243.00. The

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on United Therapeutics (UTHR – Research Report),